Lowe Wealth Advisors, LLC Amgen Inc Transaction History

Lowe Wealth Advisors, LLC

$213 Million
Q1 2024

A detailed history of Lowe Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lowe Wealth Advisors, LLC holds 204 shares of AMGN stock, worth $63,419. This represents 0.03% of its overall portfolio holdings.

Number of Shares

204

Previous 216 5.56%

Holding current value

$63,419

Previous $62,000 6.45%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 08, 2024	SELL	$268.87 - $324.56 $3,226 - $3,894	-12 Reduced 5.56%	204 $58,000
Q4 2023 Jan 04, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 4.42%	216 $62,000
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $112,604 - $139,801	-515 Reduced 69.5%	226 $60,000
Q2 2023 Jul 06, 2023	BUY	$214.27 - $253.37 $28,926 - $34,204	135 Added 22.28%	741 $164,000
Q1 2023 Apr 05, 2023	BUY	$225.79 - $275.2 $86,703 - $105,676	384 Added 172.97%	606 $146,000

Q1 2022 Apr 08, 2022	BUY	$219.27 - $242.57 $37,275 - $41,236	170 Added 326.92%	222 $54,000
Q3 2020 Oct 16, 2020	SELL	$234.65 - $260.95 $5,866 - $6,523	-25 Reduced 32.47%	52 $13,000
Q3 2019 Oct 08, 2019	SELL	$174.11 - $208.62 $5,223 - $6,258	-30 Reduced 28.04%	77 $15,000
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $16,670 - $19,541	100 Added 1428.57%	107 $20,000
Q1 2019 Apr 08, 2019	BUY	$180.87 - $203.88 $904 - $1,019	5 Added 250.0%	7 $1,000
Q4 2018 Jan 10, 2019	SELL	$178.4 - $208.25 $8,028 - $9,371	-45 Reduced 95.74%	2 $0
Q3 2018 Oct 30, 2018	BUY	$185.29 - $208.89 $8,338 - $9,400	45 Added 2250.0%	47 $10,000
Q1 2018 Apr 06, 2018	BUY	$169.43 - $198.0 $338 - $396	2 New	2 $0

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Wealth Advisors, LLC with notifications on news.

Account

Lowe Wealth Advisors, LLC Amgen Inc Transaction History